title: Acral erythema worsened by intravenous infusions of cyclosporin.
abstract: Acral erythema is a frequent cutaneous reaction related to chemotherapy. A patient presented herein developed acral erythema related to cytosine arabinoside treatment and then graft versus host disease (GVHD). Subsequently, worsening of palmar erythema and pain occurred with intravenous cyclosporin infusions.
authors.affiliation: Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain.
authors.forename: Paola
authors.initials: P
authors.lastname: Maldonado Cid
authors.forename: Elena
authors.initials: E
authors.lastname: Sendagorta Cudós
authors.forename: Lucero
authors.initials: L
authors.lastname: Noguera Morel
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez-Fernández
authors.forename: Maria José
authors.initials: MJ
authors.lastname: Beato Merino
authors.forename: Dolores
authors.initials: D
authors.lastname: Hernández-Maraver
authors.forename: Pedro
authors.initials: P
authors.lastname: Herranz Pinto
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects*; D003561:Cytarabine / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D004890:Erythema / Q000139:chemically induced* / Q000628:therapy; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D016572:Cyclosporine; D008727:Methotrexate